1.
Malapelle U, Buglioni S, Castellano I, Criscitiello C, Curigliano G, d’Amati G, De Angelis C, de Biase D, Pepe F, Perrone G, Scatena C, Scatolini M, Trapani D, Venetis K, Fusco N. Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2− metastatic breast cancer. Pathologica [Internet]. 2026 Feb. 6 [cited 2026 Feb. 7];117(6). Available from: https://www.pathologica.it/article/view/1531